288 related articles for article (PubMed ID: 7224281)
1. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
[TBL] [Abstract][Full Text] [Related]
2. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
[TBL] [Abstract][Full Text] [Related]
5. An inactivated rift valley fever vaccine.
Barnard BJ; Botha MJ
J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
8. Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever.
Hubbard KA; Baskerville A; Stephenson JR
Am J Vet Res; 1991 Jan; 52(1):50-5. PubMed ID: 2021254
[TBL] [Abstract][Full Text] [Related]
9. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
Morrill JC; Jennings GB; Caplen H; Turell MJ; Johnson AJ; Peters CJ
Am J Vet Res; 1987 Jul; 48(7):1042-7. PubMed ID: 3631685
[TBL] [Abstract][Full Text] [Related]
11. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
Morrill JC; Peters CJ
J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
Morrill JC; Peters CJ
J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
[TBL] [Abstract][Full Text] [Related]
13. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
[TBL] [Abstract][Full Text] [Related]
14. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting.
Bull World Health Organ; 1983; 61(2):261-8. PubMed ID: 6602663
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
16. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
Barnard BJ
J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
[TBL] [Abstract][Full Text] [Related]
19. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
